CoChat

CD 169‐positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma

Open access
Ohnishi, Koji, Komohara, Yoshihiro, Saito, Yoichi, Miyamoto, Yuji, Watanabe, Masayuki, Baba, Hideo, Takeya, Motohiro · 2013 · Cancer Science
Cited by 123

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

CD 169 (sialoadhesin) is a sialic acid receptor that is expressed on specific macrophages such as lymph node sinus macrophages. Animal studies have suggested that CD 169+ macrophages have a pro‐inflammatory property, however, the role of these cells in human diseases has not been clarified. In our in vitro experiments with human macrophages, pro‐inflammatory cytokines, such as type 1 interferon, induced strong expression of CD 169, suggesting that CD 169 might be a specific marker of inflammatory macrophages. To examine the role of CD 169 in antitumor immunity, we examined the expression of CD 169 in regional lymph nodes (RLN s) and its association with overall survival in colorectal carcinoma (CRC). In a clinicopathological analysis on 83 CRC patients, paraffin‐embedded specimens were evaluated for CD 169 expression of RLN macrophages by immunohistochemistry. We found, for the first time, a high density of CD 169+ macrophages was significantly associated with longer overall survival; multivariate analysis showed that the ratio of CD 169+ cells to CD 68+ cells was an independent prognostic factor. The majority of CD 169+ macrophages were in direct contact with CD 8+ T cells expressing CD 43, a major ligand of CD 169. We also found that the density of CD 169+ macrophages had a positive correlation with the number of CD 8+ cytotoxic T cells infiltrating tumor tissues. These data suggest that CD 169+ macrophages in RLN s promote CD 8+ T‐cell‐mediated antitumor immunity and are associated with a better prognosis for CRC patients. CD 169+ macrophages in RLN s could be a useful marker for assessing clinical prognosis and monitoring antitumor immunity in patients with CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cas.12212

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Ohnishi, K., Komohara, Y., Saito, Y., Miyamoto, Y., Watanabe, M., Baba, H., & Takeya, M.
Venue
Cancer Science
Publisher
Wiley
Published
2013-07-09
Volume
104
Issue
9
Pages
1237-1244
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W2023880559
Cited by
123
References
4
FWCI
3.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.